Medscape
Medscape InDiscussion: Esophageal Cancer
Listen to Medscape InDiscussion: Esophageal Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999882. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Où écouter ?
Les podcasts dans l'appli Replaio Radio Bientôt disponibleLes podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts
Installe-la gratuitement
Android près de 10 M de téléchargements · note de 4,8
iOS bientôt
Épisodes
ASCO 2024: What the ESOPEC, RENAISSANCE, and ARMANI Trials Mean for the Future of Esophageal Cancer Treatment 29.10.2024 19:37
Drs Samuel Klempner and Yelena Janjigian break down major takeaways from the clinical trial data presented at ASCO 2024. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999887. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Reso...
Emerging Biomarkers and Novel Therapies for Esophageal Cancer 26.09.2024 19:44
Drs Samuel Klempner and Haeseong Park discuss emerging biomarkers and novel therapies for esophageal cancer, including new data from ASCO. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999886. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare p...
Clinical Scenarios and Approaches to Treating Locally Advanced Esophageal Adenocarcinoma 28.08.2024 19:28
Drs Samuel Klempner and Nataliya Uboha discuss the treatment of patients with locally advanced esophageal adenocarcinomas who opt to not undergo esophagostomy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999885. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended onl...
Navigating Esophageal Squamous Cell Cancer From Diagnosis to Treatment 30.07.2024 23:40
Drs Samuel Klempner and Geoffrey Ku deep dive into all things esophageal squamous cell cancer, including detection, staging, and treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999884. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare...
Standard-of-Care, Second-Line, and Future Therapies for GEJ and Esophageal Adenocarcinoma 26.06.2024 20:50
Drs Samuel Klempner and Zev Wainberg discuss standard-of-care, second-line, and future therapies for GE junction, esophageal, and gastric cancers. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999883. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US heal...
Understanding, Detecting, and Treating Gastroesophageal Junction Adenocarcinoma 26.06.2024 21:36
Drs Samuel Klempner and Yelena Janjigian provide clinical pearls for understanding, detecting, and treating GEJ adenocarcinoma. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999882. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...
Podcasts similaires
Écoute le podcast Medscape InDiscussion: Esophageal Cancer sur Replaio
La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement
Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics
